De Novo Donor‐Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|15|12|3239-3246

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.15, Iss.12, 2015-12, pp. : 3239-3246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donor‐specific anti‐HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum complement inactivation unveiled prepregnancy donor‐specific HLA antibodies leading to postpartum kidney graft loss

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 5, 2015-05 ,pp. : 623-625

John Wiley & Sons Inc

Access to resources Recommend Favorite

De novo donor‐specific anti‐HLA antibodies mediated rejection in liver‐transplant patients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 12, 2015-12 ,pp. : 1371-1382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Many de novo donor‐specific antibodies recognize β2‐microglobulin‐free, but not intact HLA heterodimers

By  

HLA, Vol. 87, Iss. 5, 2016-05 ,pp. : 356-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical impact of preformed donor‐specific denatured class I HLA antibodies after kidney transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 5, 2015-05 ,pp. : 393-402

John Wiley & Sons Inc

Access to resources Recommend Favorite